|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer |
Vir: |
|
|
|
List of services to meet your request
Contains list of services for current record
|
|
|
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
|